Scholar Rock targets September 30 PDUFA decision with 2 independent fill/finish paths (NASDAQ:SRRK)
· seekingalpha.com
Scholar Rock (SRRK) Q2 2026 earnings call: apitegromab PDUFA Sept 30, dual manufacturing paths, launch readiness, cash runway & risks.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...